跳至主要内容
临床试验/NCT00813761
NCT00813761已完成不适用

Clinical Evaluation of the Long-Term Effects of Contact Lens Care Systems

Johnson & Johnson Vision Care, Inc.26 个研究点 分布在 2 个国家目标入组 473 人开始时间: 2008年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
473
试验地点
26
主要终点
Lens Comfort

研究概览

简要总结

The purpose of this study is to compare two marketed contact lens care solutions in regards to comfort and ocular health.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Be at least 18 years old.
  • Signed Informed Consent and Investigator to record this on Case Report Form (CRF) in appropriate space.
  • Require a visual correction in both eyes (monovision allowed but not monofit).
  • Have a contact lens spherical distance requirement between +6.00D and -9.00D in both eyes.
  • Astigmatism of 1.00D or less in the better eye and 1.50D or less in the other eye.
  • Be correctable to a visual acuity of 20/30 (6/9) or better in each eye.
  • Have normal eyes with no evidence of abnormality or disease.

排除标准

  • Requires concurrent ocular medication.
  • Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear.
  • Clinically significant corneal edema, corneal vascularisation, tarsal abnormalities, bulbar injection or any other abnormality of the cornea that would contraindicate contact lens wear.
  • Worn lenses on an extended wear basis in the last 3 months.
  • Diabetic.
  • Infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease (e.g., HIV).
  • Polymethyl methacrylate (PMMA) or rigid gas-permeable (RGP) lens wear in the previous 8 weeks.
  • Has had refractive surgery. Has had eye injury/surgery within 8 weeks immediately prior to enrolment for this study.
  • Abnormal lacrimal secretions.

研究组 & 干预措施

02Optix CL and ReNu MPS with SICS

Other

O2Optix contact lens and ReNu MultiPlus Multi-Purpose Solution

干预措施: O2Optix contact lens (Device)

02Optix CL and ReNu MPS with SICS

Other

O2Optix contact lens and ReNu MultiPlus Multi-Purpose Solution

干预措施: ReNu MultiPlus Multi-Purpose Solution (Device)

Proclear CL and ReNu MPS with SICS

Other

Proclear contact lens and ReNu MultiPlus Multi-Purpose Solution

干预措施: Proclear contact lens (Device)

Proclear CL and ReNu MPS with SICS

Other

Proclear contact lens and ReNu MultiPlus Multi-Purpose Solution

干预措施: ReNu MultiPlus Multi-Purpose Solution (Device)

02Optix CL and Clear Care LCS with SICS

Other

O2Optix contact lens and Clear Care lens care solution subject

干预措施: O2Optix contact lens (Device)

02Optix CL and Clear Care LCS with SICS

Other

O2Optix contact lens and Clear Care lens care solution subject

干预措施: Clear Care Cleaning and Disinfecting Solution (Device)

Proclear CL and Clear Care LCS with SICS

Other

Proclear contact lens and Clear Care lens care solution

干预措施: Proclear contact lens (Device)

Proclear CL and Clear Care LCS with SICS

Other

Proclear contact lens and Clear Care lens care solution

干预措施: Clear Care Cleaning and Disinfecting Solution (Device)

02Optix CL and ReNu MPS without SICS

Other

O2Optix contact lens and ReNu MultiPlus Multi-Purpose Solution

干预措施: O2Optix contact lens (Device)

02Optix CL and ReNu MPS without SICS

Other

O2Optix contact lens and ReNu MultiPlus Multi-Purpose Solution

干预措施: ReNu MultiPlus Multi-Purpose Solution (Device)

Proclear CL and ReNu MPS without SICS

Other

Proclear contact lens and ReNu MultiPlus Multi-Purpose Solution

干预措施: Proclear contact lens (Device)

Proclear CL and ReNu MPS without SICS

Other

Proclear contact lens and ReNu MultiPlus Multi-Purpose Solution

干预措施: ReNu MultiPlus Multi-Purpose Solution (Device)

02Optix CL and Clear Care LCS without SICS

Other

O2Optix contact lens and Clear Care lens care solution

干预措施: O2Optix contact lens (Device)

02Optix CL and Clear Care LCS without SICS

Other

O2Optix contact lens and Clear Care lens care solution

干预措施: Clear Care Cleaning and Disinfecting Solution (Device)

Proclear CL and Clear Care LCS without SICS

Other

Proclear contact lens and Clear Care lens care solution

干预措施: Proclear contact lens (Device)

Proclear CL and Clear Care LCS without SICS

Other

Proclear contact lens and Clear Care lens care solution

干预措施: Clear Care Cleaning and Disinfecting Solution (Device)

结局指标

主要结局

Lens Comfort

时间窗: 24 weeks

Lens comfort at time of month 6 visit, using a scale of 0 to 10, where 10=excellent.

Average Daily Comfortable Wear Time

时间窗: 24 weeks

Average hours per day that contact lens were worn comfortably.

Frequency of Eye Discomfort

时间窗: 24 weeks

Subjective measure of typical daily eye discomfort reported at month 6 visit using a scale of 0 to 3. 0=Never, 1=Infrequently, 2=Frequently, 3=Constantly.

Limbal Redness

时间窗: 24 weeks

Redness at the transition zone between the white of the eye and the clear window of the eye, the cornea, on a scale of 0 to 4. 0=None, 1=Trace, 2=Mild, 3=Moderate, 4=Severe

Frequency of Daily Lens Dryness

时间窗: 24 weeks

Subjective measure of typical daily contact lens dryness reported at month 6 visit using a scale of 0 to 3. 0=Never, 1=Infrequently, 2=Frequently, 3=Constantly.

Frequency of Itching

时间窗: 24 weeks

Subjective measure of typical daily eye burning and stinging reported at month 6 visit using a scale of 0 to 3. 0=Never, 1=Infrequently, 2=Frequently, 3=Constantly.

Frequency of Tearing

时间窗: 24 weeks

Subjective measure of typical daily tearing related to lens wear reported at month 6 visit using a scale of 0 to 3. 0=Never, 1=Infrequently, 2=Frequently, 3=Constantly.

Average Corneal Fluorescein Staining Area

时间窗: 24 weeks

corneal staining measured over 5 areas, averaged, and graded as a single score average on a scale of 0 to 10, 0=0%, 1=10%, 2=20%, 3=30%, 4=40%, 5=50%, 6=60%, 7=70%, 8=80%, 9=90%, 10=100%.

Average Daily Wear Time

时间窗: 24 weeks

Average hours per day that contact lens were worn.

Frequency of Eye Burning/Stinging

时间窗: 24 weeks

Subjective measure of typical daily eye burning and stinging reported at month 6 visit using a scale of 0 to 3. 0=Never, 1=Infrequently, 2=Frequently, 3=Constantly.

Tarsal Roughness

时间窗: 24 weeks

The roughness of the inner lining of the eyelids, measured on a 0 to 7 scale. 0=Smooth, 1=Slightly uneven, 2=Uneven surface, 3=Uneven surface with loss of transparency \& superficial vessels, 4=Small papillae, poor transparency, 5=Papillae greater than 0.5mm in size, no transparency, 6=Papillae greater than 0.5mm in size, vessels inside papillae, 7=Large papillae

Average Corneal Fluorescein Type Staining

时间窗: 24 weeks

staining measured over five sectors of the cornea and classified as a type of staining on a scale of 0 to 4. 0=None, 1=Micropunctate, 2=Macropunctate, 3=Coalesced Macropunctate, 4=Patch.

Bulbar Redness

时间窗: 24 weeks

Redness of the blood vessels in the tissues overlaying the white of the eye, on a scale of 0 to 4. 0=None, 1=Trace, 2=Mild, 3=Moderate, 4=Severe

Upper Tarsal Redness

时间窗: 24 weeks

Redness of the blood vessels in the inner lining of the upper eyelid, on a scale of 0 to 4. 0=None, 1=Trace, 2=Mild, 3=Moderate, 4=Severe

Lower Tarsal Redness

时间窗: 24 weeks

Redness of the blood vessels in the inner lining of the lower eyelid, on a scale of 0 to 4. 0=None, 1=Trace, 2=Mild, 3=Moderate, 4=Severe

次要结局

  • Intensity of Physiological Outcomes(24 weeks)
  • Wearing Time and Comfortable Wearing Time(24 weeks)
  • Physiological Responses(24 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (26)

Loading locations...

相似试验